← All stocks

Replimune Group, Inc.

REPL No buying or selling

CIK 0001737953 #2319 in the set updated 18 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

7 insiders · 0 transactions

14.4×

Sushil Patel holds 14.4 times base salary in stock. $10.11M of shares against $700.00K in salary for 2026.

Salary from the company's own proxy. The shares are what Sushil Patel last reported holding, valued at $14.28, the price Common Stock was last bought or sold at on the open market here, on 17 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Astley-Sparke Philip

Director

—

1,362,414

1.62%

$19.46M

−5.2%

Patel Sushil

Chief Executive Officer

—

708,151

0.8436%

$10.11M

+234.0%

Xynos Konstantinos

Chief Medical Officer

—

224,215

0.2671%

$3.20M

+91.4%

Hill Emily Luisa

Chief Financial Officer

—

215,852

0.2571%

$3.08M

+113.6%

Sarchi Christopher

Chief Commercial Officer

—

180,962

0.2156%

$2.58M

+96.2%

Schwendenman Andrew

Chief Accounting Officer

—

99,425

0.1184%

$1.42M

−44.2%

Dhingra Kapil

Director

—

0.0000%

$0.00

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 50,000

History held since 25 Jul 2018